nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLC7A11—forelimb zeugopod—muscle cancer	0.128	0.264	CbGeAlD
Acetylcysteine—ACY1—renal system—muscle cancer	0.022	0.0453	CbGeAlD
Acetylcysteine—CHUK—renal system—muscle cancer	0.0152	0.0313	CbGeAlD
Acetylcysteine—ACY1—head—muscle cancer	0.0147	0.0303	CbGeAlD
Acetylcysteine—ACY1—testis—muscle cancer	0.0142	0.0293	CbGeAlD
Acetylcysteine—IKBKB—embryo—muscle cancer	0.0136	0.0281	CbGeAlD
Acetylcysteine—SLC7A11—smooth muscle tissue—muscle cancer	0.013	0.0267	CbGeAlD
Acetylcysteine—SLC7A11—renal system—muscle cancer	0.0125	0.0257	CbGeAlD
Acetylcysteine—GRIN2D—tendon—muscle cancer	0.0121	0.025	CbGeAlD
Acetylcysteine—IKBKB—smooth muscle tissue—muscle cancer	0.0107	0.0221	CbGeAlD
Acetylcysteine—GSS—smooth muscle tissue—muscle cancer	0.0105	0.0217	CbGeAlD
Acetylcysteine—GRIN2D—head—muscle cancer	0.0104	0.0215	CbGeAlD
Acetylcysteine—CHUK—head—muscle cancer	0.0101	0.0209	CbGeAlD
Acetylcysteine—GSS—renal system—muscle cancer	0.0101	0.0209	CbGeAlD
Acetylcysteine—GRIN2D—testis—muscle cancer	0.0101	0.0207	CbGeAlD
Acetylcysteine—CHUK—testis—muscle cancer	0.0098	0.0202	CbGeAlD
Acetylcysteine—GRIN3A—head—muscle cancer	0.00979	0.0202	CbGeAlD
Acetylcysteine—GRIN3A—testis—muscle cancer	0.00946	0.0195	CbGeAlD
Acetylcysteine—GRIN1—head—muscle cancer	0.00928	0.0191	CbGeAlD
Acetylcysteine—GSS—cardiac atrium—muscle cancer	0.00906	0.0187	CbGeAlD
Acetylcysteine—GRIN2A—tendon—muscle cancer	0.00903	0.0186	CbGeAlD
Acetylcysteine—GRIN2B—head—muscle cancer	0.00885	0.0182	CbGeAlD
Acetylcysteine—GRIN2A—vagina—muscle cancer	0.00838	0.0173	CbGeAlD
Acetylcysteine—SLC7A11—head—muscle cancer	0.00836	0.0172	CbGeAlD
Acetylcysteine—SLC7A11—testis—muscle cancer	0.00807	0.0166	CbGeAlD
Acetylcysteine—IKBKB—tendon—muscle cancer	0.00805	0.0166	CbGeAlD
Acetylcysteine—GSS—tendon—muscle cancer	0.0079	0.0163	CbGeAlD
Acetylcysteine—GRIN2A—head—muscle cancer	0.00774	0.0159	CbGeAlD
Acetylcysteine—GSS—bone marrow—muscle cancer	0.00765	0.0158	CbGeAlD
Acetylcysteine—GRIN2A—testis—muscle cancer	0.00748	0.0154	CbGeAlD
Acetylcysteine—IKBKB—vagina—muscle cancer	0.00747	0.0154	CbGeAlD
Acetylcysteine—SLCO1B1—renal system—muscle cancer	0.00744	0.0153	CbGeAlD
Acetylcysteine—GSS—vagina—muscle cancer	0.00733	0.0151	CbGeAlD
Acetylcysteine—IKBKB—head—muscle cancer	0.0069	0.0142	CbGeAlD
Acetylcysteine—GSS—head—muscle cancer	0.00677	0.014	CbGeAlD
Acetylcysteine—IKBKB—testis—muscle cancer	0.00666	0.0137	CbGeAlD
Acetylcysteine—GSS—testis—muscle cancer	0.00654	0.0135	CbGeAlD
Acetylcysteine—Throat tightness—Etoposide—muscle cancer	0.00522	0.0425	CcSEcCtD
Acetylcysteine—Respiratory distress—Vincristine—muscle cancer	0.00498	0.0405	CcSEcCtD
Acetylcysteine—Sensitisation—Doxorubicin—muscle cancer	0.00372	0.0302	CcSEcCtD
Acetylcysteine—Gait disturbance—Vincristine—muscle cancer	0.00324	0.0263	CcSEcCtD
Acetylcysteine—Chest discomfort—Etoposide—muscle cancer	0.0029	0.0235	CcSEcCtD
Acetylcysteine—GRIN1—BDNF signaling pathway—CNR1—muscle cancer	0.00243	0.0062	CbGpPWpGaD
Acetylcysteine—GRIN2B—BDNF signaling pathway—CNR1—muscle cancer	0.00237	0.00604	CbGpPWpGaD
Acetylcysteine—CHUK—AGE/RAGE pathway—FOXO1—muscle cancer	0.00231	0.00589	CbGpPWpGaD
Acetylcysteine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—FOXO1—muscle cancer	0.00228	0.00582	CbGpPWpGaD
Acetylcysteine—CHUK—PI-3K cascade—FOXO4—muscle cancer	0.00228	0.00581	CbGpPWpGaD
Acetylcysteine—CHUK—PI3K/AKT activation—FOXO4—muscle cancer	0.00222	0.00567	CbGpPWpGaD
Acetylcysteine—CHUK—GAB1 signalosome—FOXO4—muscle cancer	0.0022	0.00563	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MYOG—muscle cancer	0.0022	0.00561	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—ANGPT2—muscle cancer	0.00217	0.00553	CbGpPWpGaD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—FOXO4—muscle cancer	0.00215	0.0055	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MYOG—muscle cancer	0.00214	0.00547	CbGpPWpGaD
Acetylcysteine—IKBKB—AGE/RAGE pathway—FOXO1—muscle cancer	0.00209	0.00534	CbGpPWpGaD
Acetylcysteine—CHUK—Leptin signaling pathway—FOXO1—muscle cancer	0.00208	0.00531	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—IGF2—muscle cancer	0.00207	0.00527	CbGpPWpGaD
Acetylcysteine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—FOXO1—muscle cancer	0.00207	0.00527	CbGpPWpGaD
Acetylcysteine—Stomatitis—Dactinomycin—muscle cancer	0.00193	0.0157	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Etoposide—muscle cancer	0.00192	0.0156	CcSEcCtD
Acetylcysteine—IKBKB—Leptin signaling pathway—FOXO1—muscle cancer	0.00189	0.00482	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—IGF2—muscle cancer	0.00187	0.00478	CbGpPWpGaD
Acetylcysteine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—FOXO1—muscle cancer	0.00187	0.00476	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.00182	0.00466	CbGpPWpGaD
Acetylcysteine—Haemoptysis—Doxorubicin—muscle cancer	0.0018	0.0146	CcSEcCtD
Acetylcysteine—Pharyngitis—Dactinomycin—muscle cancer	0.00176	0.0143	CcSEcCtD
Acetylcysteine—Stomatitis—Vincristine—muscle cancer	0.00172	0.014	CcSEcCtD
Acetylcysteine—CHUK—Signaling by SCF-KIT—FOXO4—muscle cancer	0.0017	0.00434	CbGpPWpGaD
Acetylcysteine—Sweating—Vincristine—muscle cancer	0.0017	0.0138	CcSEcCtD
Acetylcysteine—CHUK—B Cell Receptor Signaling Pathway—FOXO1—muscle cancer	0.00169	0.00433	CbGpPWpGaD
Acetylcysteine—Feeling hot—Doxorubicin—muscle cancer	0.00169	0.0138	CcSEcCtD
Acetylcysteine—CHUK—PI-3K cascade—FOXO1—muscle cancer	0.00168	0.00429	CbGpPWpGaD
Acetylcysteine—CHUK—Validated transcriptional targets of TAp63 isoforms—CDKN2A—muscle cancer	0.00167	0.00428	CbGpPWpGaD
Acetylcysteine—Flushing—Dactinomycin—muscle cancer	0.00165	0.0134	CcSEcCtD
Acetylcysteine—CHUK—BDNF signaling pathway—CNR1—muscle cancer	0.00164	0.00419	CbGpPWpGaD
Acetylcysteine—CHUK—PI3K/AKT activation—FOXO1—muscle cancer	0.00164	0.00419	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—FH—muscle cancer	0.00163	0.00416	CbGpPWpGaD
Acetylcysteine—CHUK—GAB1 signalosome—FOXO1—muscle cancer	0.00163	0.00416	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—FOXO4—muscle cancer	0.00163	0.00416	CbGpPWpGaD
Acetylcysteine—CHUK—Validated transcriptional targets of TAp63 isoforms—MDM2—muscle cancer	0.00162	0.00415	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—MED12—muscle cancer	0.0016	0.00409	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—FOXO4—muscle cancer	0.0016	0.00409	CbGpPWpGaD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—FOXO1—muscle cancer	0.00159	0.00406	CbGpPWpGaD
Acetylcysteine—Bronchospasm—Etoposide—muscle cancer	0.00158	0.0128	CcSEcCtD
Acetylcysteine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—muscle cancer	0.00156	0.004	CbGpPWpGaD
Acetylcysteine—Erythema—Dactinomycin—muscle cancer	0.00155	0.0126	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—FOXO1—muscle cancer	0.00154	0.00392	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—FOXO4—muscle cancer	0.00153	0.00391	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—FOXO4—muscle cancer	0.00152	0.00389	CbGpPWpGaD
Acetylcysteine—IKBKB—Validated transcriptional targets of TAp63 isoforms—CDKN2A—muscle cancer	0.00152	0.00388	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—FOXO4—muscle cancer	0.00151	0.00387	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—FOXO4—muscle cancer	0.00151	0.00385	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—CNR1—muscle cancer	0.00149	0.0038	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FOXO4—muscle cancer	0.00149	0.00379	CbGpPWpGaD
Acetylcysteine—Cardiac disorder—Vincristine—muscle cancer	0.00147	0.012	CcSEcCtD
Acetylcysteine—IKBKB—Validated transcriptional targets of TAp63 isoforms—MDM2—muscle cancer	0.00147	0.00376	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—ENO2—muscle cancer	0.00146	0.00373	CbGpPWpGaD
Acetylcysteine—Thinking abnormal—Doxorubicin—muscle cancer	0.00145	0.0118	CcSEcCtD
Acetylcysteine—Angiopathy—Vincristine—muscle cancer	0.00144	0.0117	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Vincristine—muscle cancer	0.00143	0.0116	CcSEcCtD
Acetylcysteine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—KIT—muscle cancer	0.00142	0.00363	CbGpPWpGaD
Acetylcysteine—GRIN2D—Alzheimers Disease—TP53—muscle cancer	0.00142	0.00362	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—FOXO4—muscle cancer	0.00142	0.00362	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—FOXO4—muscle cancer	0.00142	0.00362	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—FOXO4—muscle cancer	0.00142	0.00362	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—FOXO4—muscle cancer	0.00141	0.00359	CbGpPWpGaD
Acetylcysteine—Stomatitis—Etoposide—muscle cancer	0.0014	0.0114	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—FOXO4—muscle cancer	0.00139	0.00356	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—FOXO4—muscle cancer	0.00139	0.00354	CbGpPWpGaD
Acetylcysteine—Gait disturbance—Doxorubicin—muscle cancer	0.00136	0.0111	CcSEcCtD
Acetylcysteine—GRIN1—Developmental Biology—MYOD1—muscle cancer	0.00136	0.00346	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FOXO4—muscle cancer	0.00135	0.00344	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.00133	0.00341	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MYOD1—muscle cancer	0.00132	0.00338	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—FOXO4—muscle cancer	0.00131	0.00335	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—FOXO4—muscle cancer	0.00129	0.00328	CbGpPWpGaD
Acetylcysteine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—muscle cancer	0.00129	0.00328	CbGpPWpGaD
Acetylcysteine—CHUK—PI-3K cascade—KIT—muscle cancer	0.00128	0.00327	CbGpPWpGaD
Acetylcysteine—Oedema—Dactinomycin—muscle cancer	0.00126	0.0103	CcSEcCtD
Acetylcysteine—CHUK—Signaling by SCF-KIT—FOXO1—muscle cancer	0.00126	0.00321	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—FOXO4—muscle cancer	0.00126	0.00321	CbGpPWpGaD
Acetylcysteine—CHUK—PI3K/AKT activation—KIT—muscle cancer	0.00125	0.00319	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MED12—muscle cancer	0.00124	0.00317	CbGpPWpGaD
Acetylcysteine—CHUK—GAB1 signalosome—KIT—muscle cancer	0.00124	0.00317	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—PTGS2—muscle cancer	0.00124	0.00316	CbGpPWpGaD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—muscle cancer	0.00121	0.00309	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MED12—muscle cancer	0.00121	0.00309	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—FOXO1—muscle cancer	0.0012	0.00307	CbGpPWpGaD
Acetylcysteine—Cardiac disorder—Etoposide—muscle cancer	0.00119	0.0097	CcSEcCtD
Acetylcysteine—Flushing—Etoposide—muscle cancer	0.00119	0.0097	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Activation—FOXO4—muscle cancer	0.00119	0.00304	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	0.00119	0.00304	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—FOXO1—muscle cancer	0.00118	0.00302	CbGpPWpGaD
Acetylcysteine—GRIN2D—Transmission across Chemical Synapses—MDM2—muscle cancer	0.00118	0.003	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—CDKN2A—muscle cancer	0.00118	0.003	CbGpPWpGaD
Acetylcysteine—GRIN1—EPH-Ephrin signaling—VEGFA—muscle cancer	0.00117	0.00299	CbGpPWpGaD
Acetylcysteine—Angiopathy—Etoposide—muscle cancer	0.00117	0.00949	CcSEcCtD
Acetylcysteine—GRIN2A—Alzheimers Disease—TP53—muscle cancer	0.00117	0.00298	CbGpPWpGaD
Acetylcysteine—Immune system disorder—Etoposide—muscle cancer	0.00116	0.00944	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Etoposide—muscle cancer	0.00116	0.00942	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—muscle cancer	0.00115	0.00937	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00115	0.00935	CcSEcCtD
Acetylcysteine—GRIN2B—EPH-Ephrin signaling—VEGFA—muscle cancer	0.00114	0.00291	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—MDM2—muscle cancer	0.00114	0.00291	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—FOXO1—muscle cancer	0.00113	0.00288	CbGpPWpGaD
Acetylcysteine—Oedema—Vincristine—muscle cancer	0.00113	0.00917	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Vincristine—muscle cancer	0.00113	0.00917	CcSEcCtD
Acetylcysteine—CHUK—Signaling by FGFR—FOXO1—muscle cancer	0.00112	0.00287	CbGpPWpGaD
Acetylcysteine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—muscle cancer	0.00112	0.00286	CbGpPWpGaD
Acetylcysteine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—MDM2—muscle cancer	0.00112	0.00286	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—FOXO1—muscle cancer	0.00112	0.00286	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—FOXO1—muscle cancer	0.00111	0.00284	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—muscle cancer	0.0011	0.0028	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—muscle cancer	0.00109	0.00279	CbGpPWpGaD
Acetylcysteine—Hyperhidrosis—Vincristine—muscle cancer	0.00109	0.00886	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—muscle cancer	0.00107	0.00868	CcSEcCtD
Acetylcysteine—IKBKB—Apoptosis—CDKN2A—muscle cancer	0.00107	0.00272	CbGpPWpGaD
Acetylcysteine—Hypotension—Vincristine—muscle cancer	0.00105	0.00857	CcSEcCtD
Acetylcysteine—SLC7A11—Hemostasis—IGF2—muscle cancer	0.00105	0.00269	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	0.00105	0.00267	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—FOXO1—muscle cancer	0.00105	0.00267	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—FOXO1—muscle cancer	0.00105	0.00267	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—FOXO1—muscle cancer	0.00104	0.00265	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—MDM2—muscle cancer	0.00103	0.00264	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—FOXO1—muscle cancer	0.00103	0.00263	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—FOXO1—muscle cancer	0.00103	0.00263	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—FOXO1—muscle cancer	0.00102	0.00261	CbGpPWpGaD
Acetylcysteine—GRIN1—Alzheimers Disease—TP53—muscle cancer	0.00102	0.0026	CbGpPWpGaD
Acetylcysteine—CHUK—PI-3K cascade—MDM2—muscle cancer	0.00101	0.00257	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—muscle cancer	0.001	0.00255	CbGpPWpGaD
Acetylcysteine—Body temperature increased—Dactinomycin—muscle cancer	0.000998	0.00811	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000997	0.0081	CcSEcCtD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—muscle cancer	0.000995	0.00254	CbGpPWpGaD
Acetylcysteine—GRIN2B—Alzheimers Disease—TP53—muscle cancer	0.000991	0.00253	CbGpPWpGaD
Acetylcysteine—CHUK—PI3K/AKT activation—MDM2—muscle cancer	0.000984	0.00251	CbGpPWpGaD
Acetylcysteine—Loss of consciousness—Etoposide—muscle cancer	0.000984	0.008	CcSEcCtD
Acetylcysteine—Cough—Etoposide—muscle cancer	0.000977	0.00794	CcSEcCtD
Acetylcysteine—CHUK—GAB1 signalosome—MDM2—muscle cancer	0.000977	0.00249	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000974	0.00792	CcSEcCtD
Acetylcysteine—CHUK—B Cell Activation—FOXO1—muscle cancer	0.000969	0.00247	CbGpPWpGaD
Acetylcysteine—GRIN2A—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000966	0.00247	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—FOXO4—muscle cancer	0.000966	0.00247	CbGpPWpGaD
Acetylcysteine—Asthma—Methotrexate—muscle cancer	0.000963	0.00782	CcSEcCtD
Acetylcysteine—CHUK—Signaling by SCF-KIT—KIT—muscle cancer	0.000957	0.00244	CbGpPWpGaD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—MDM2—muscle cancer	0.000954	0.00244	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	0.00095	0.00242	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000947	0.0077	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—muscle cancer	0.000931	0.00757	CcSEcCtD
Acetylcysteine—Hypersensitivity—Dactinomycin—muscle cancer	0.00093	0.00756	CcSEcCtD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.000928	0.00237	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—MED12—muscle cancer	0.000921	0.00235	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—KIT—muscle cancer	0.000916	0.00234	CbGpPWpGaD
Acetylcysteine—Anaphylactic shock—Etoposide—muscle cancer	0.000914	0.00743	CcSEcCtD
Acetylcysteine—GRIN2D—Neuronal System—MDM2—muscle cancer	0.000901	0.0023	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—KIT—muscle cancer	0.000901	0.0023	CbGpPWpGaD
Acetylcysteine—Tachycardia—Etoposide—muscle cancer	0.000892	0.00725	CcSEcCtD
Acetylcysteine—Body temperature increased—Vincristine—muscle cancer	0.000892	0.00725	CcSEcCtD
Acetylcysteine—Skin disorder—Etoposide—muscle cancer	0.000888	0.00721	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Etoposide—muscle cancer	0.000884	0.00718	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Activation—FOXO1—muscle cancer	0.000879	0.00224	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—FOXO4—muscle cancer	0.000876	0.00224	CbGpPWpGaD
Acetylcysteine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000863	0.00701	CcSEcCtD
Acetylcysteine—CHUK—Downstream signal transduction—KIT—muscle cancer	0.000861	0.0022	CbGpPWpGaD
Acetylcysteine—Drowsiness—Methotrexate—muscle cancer	0.000858	0.00698	CcSEcCtD
Acetylcysteine—CHUK—Signaling by FGFR—KIT—muscle cancer	0.000857	0.00219	CbGpPWpGaD
Acetylcysteine—Hypotension—Etoposide—muscle cancer	0.000854	0.00694	CcSEcCtD
Acetylcysteine—CHUK—Signaling by ERBB2—KIT—muscle cancer	0.000852	0.00218	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—KIT—muscle cancer	0.000848	0.00217	CbGpPWpGaD
Acetylcysteine—GRIN1—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000843	0.00215	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—ENO2—muscle cancer	0.000839	0.00214	CbGpPWpGaD
Acetylcysteine—Stomatitis—Methotrexate—muscle cancer	0.000837	0.0068	CcSEcCtD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	0.000836	0.00213	CbGpPWpGaD
Acetylcysteine—Asthma—Doxorubicin—muscle cancer	0.000834	0.00677	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vincristine—muscle cancer	0.000831	0.00676	CcSEcCtD
Acetylcysteine—Sweating—Methotrexate—muscle cancer	0.000823	0.00669	CcSEcCtD
Acetylcysteine—GRIN2B—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000821	0.0021	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Etoposide—muscle cancer	0.000815	0.00662	CcSEcCtD
Acetylcysteine—Somnolence—Etoposide—muscle cancer	0.000813	0.0066	CcSEcCtD
Acetylcysteine—Vomiting—Dactinomycin—muscle cancer	0.000803	0.00653	CcSEcCtD
Acetylcysteine—CHUK—Signaling by FGFR in disease—KIT—muscle cancer	0.000798	0.00204	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—KIT—muscle cancer	0.000798	0.00204	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	0.000798	0.00204	CbGpPWpGaD
Acetylcysteine—Rash—Dactinomycin—muscle cancer	0.000796	0.00647	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR—KIT—muscle cancer	0.000791	0.00202	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000789	0.00641	CcSEcCtD
Acetylcysteine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	0.000784	0.002	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—KIT—muscle cancer	0.000784	0.002	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000781	0.00199	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—KIT—muscle cancer	0.00078	0.00199	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD34—muscle cancer	0.000778	0.00199	CbGpPWpGaD
Acetylcysteine—CHUK—p75(NTR)-mediated signaling—TP53—muscle cancer	0.000766	0.00196	CbGpPWpGaD
Acetylcysteine—Pharyngitis—Methotrexate—muscle cancer	0.000765	0.00622	CcSEcCtD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	0.000758	0.00194	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—MDM2—muscle cancer	0.000754	0.00192	CbGpPWpGaD
Acetylcysteine—Nausea—Dactinomycin—muscle cancer	0.00075	0.0061	CcSEcCtD
Acetylcysteine—Dizziness—Vincristine—muscle cancer	0.000746	0.00606	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—muscle cancer	0.000743	0.00604	CcSEcCtD
Acetylcysteine—GRIN2A—Neuronal System—MDM2—muscle cancer	0.00074	0.00189	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—KIT—muscle cancer	0.000738	0.00189	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—TP53—muscle cancer	0.000737	0.00188	CbGpPWpGaD
Acetylcysteine—Urticaria—Etoposide—muscle cancer	0.000726	0.0059	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—muscle cancer	0.000725	0.00589	CcSEcCtD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	0.000724	0.00185	CbGpPWpGaD
Acetylcysteine—Body temperature increased—Etoposide—muscle cancer	0.000723	0.00587	CcSEcCtD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000721	0.00184	CbGpPWpGaD
Acetylcysteine—Vomiting—Vincristine—muscle cancer	0.000717	0.00583	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—muscle cancer	0.000715	0.00581	CcSEcCtD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—MDM2—muscle cancer	0.000714	0.00182	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—FOXO1—muscle cancer	0.000713	0.00182	CbGpPWpGaD
Acetylcysteine—Sweating—Doxorubicin—muscle cancer	0.000713	0.00579	CcSEcCtD
Acetylcysteine—Rash—Vincristine—muscle cancer	0.000711	0.00578	CcSEcCtD
Acetylcysteine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	0.000711	0.00182	CbGpPWpGaD
Acetylcysteine—Dermatitis—Vincristine—muscle cancer	0.000711	0.00578	CcSEcCtD
Acetylcysteine—CHUK—Signaling by ERBB4—MDM2—muscle cancer	0.00071	0.00181	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000707	0.0018	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD34—muscle cancer	0.000706	0.0018	CbGpPWpGaD
Acetylcysteine—Angiopathy—Methotrexate—muscle cancer	0.000699	0.00568	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—muscle cancer	0.000696	0.00566	CcSEcCtD
Acetylcysteine—IKBKB—p75(NTR)-mediated signaling—TP53—muscle cancer	0.000695	0.00177	CbGpPWpGaD
Acetylcysteine—Mediastinal disorder—Methotrexate—muscle cancer	0.000695	0.00564	CcSEcCtD
Acetylcysteine—GRIN1—Developmental Biology—FOXO1—muscle cancer	0.000681	0.00174	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—MDM2—muscle cancer	0.000678	0.00173	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—MDM2—muscle cancer	0.000675	0.00172	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Etoposide—muscle cancer	0.000673	0.00547	CcSEcCtD
Acetylcysteine—CHUK—Signaling by ERBB2—MDM2—muscle cancer	0.000671	0.00171	CbGpPWpGaD
Acetylcysteine—Erythema—Methotrexate—muscle cancer	0.000671	0.00545	CcSEcCtD
Acetylcysteine—Nausea—Vincristine—muscle cancer	0.00067	0.00545	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Activation—KIT—muscle cancer	0.00067	0.00171	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—MDM2—muscle cancer	0.000668	0.00171	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—FOXO1—muscle cancer	0.000664	0.0017	CbGpPWpGaD
Acetylcysteine—Pharyngitis—Doxorubicin—muscle cancer	0.000662	0.00538	CcSEcCtD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	0.000658	0.00168	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TP53—muscle cancer	0.000655	0.00167	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—FOXO1—muscle cancer	0.000647	0.00165	CbGpPWpGaD
Acetylcysteine—Pruritus—Etoposide—muscle cancer	0.000647	0.00526	CcSEcCtD
Acetylcysteine—GRIN1—Neuronal System—MDM2—muscle cancer	0.000646	0.00165	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neuronal System—MDM2—muscle cancer	0.000629	0.00161	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000629	0.00161	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000628	0.0016	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—MDM2—muscle cancer	0.000628	0.0016	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—MDM2—muscle cancer	0.000628	0.0016	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—MDM2—muscle cancer	0.000623	0.00159	CbGpPWpGaD
Acetylcysteine—Cardiac disorder—Doxorubicin—muscle cancer	0.000619	0.00503	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—muscle cancer	0.000619	0.00503	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000617	0.00158	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—MDM2—muscle cancer	0.000615	0.00157	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KIDINS220—muscle cancer	0.000613	0.00156	CbGpPWpGaD
Acetylcysteine—Angiopathy—Doxorubicin—muscle cancer	0.000605	0.00492	CcSEcCtD
Acetylcysteine—Dizziness—Etoposide—muscle cancer	0.000604	0.00491	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—muscle cancer	0.000603	0.0049	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000601	0.00489	CcSEcCtD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	0.000597	0.00152	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—TP53—muscle cancer	0.000594	0.00152	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000591	0.00151	CbGpPWpGaD
Acetylcysteine—Cough—Methotrexate—muscle cancer	0.000585	0.00476	CcSEcCtD
Acetylcysteine—CHUK—B Cell Activation—MDM2—muscle cancer	0.000582	0.00148	CbGpPWpGaD
Acetylcysteine—Vomiting—Etoposide—muscle cancer	0.000581	0.00472	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—muscle cancer	0.000581	0.00472	CcSEcCtD
Acetylcysteine—Rash—Etoposide—muscle cancer	0.000576	0.00468	CcSEcCtD
Acetylcysteine—Dermatitis—Etoposide—muscle cancer	0.000576	0.00468	CcSEcCtD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.00057	0.00146	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.00057	0.00145	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000567	0.00461	CcSEcCtD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—TP53—muscle cancer	0.000557	0.00142	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000557	0.00142	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KIDINS220—muscle cancer	0.000556	0.00142	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—FOXO4—muscle cancer	0.000551	0.00141	CbGpPWpGaD
Acetylcysteine—Anaphylactic shock—Methotrexate—muscle cancer	0.000547	0.00445	CcSEcCtD
Acetylcysteine—CHUK—Signaling by NGF—KIT—muscle cancer	0.000544	0.00139	CbGpPWpGaD
Acetylcysteine—Nausea—Etoposide—muscle cancer	0.000543	0.00441	CcSEcCtD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	0.000542	0.00138	CbGpPWpGaD
Acetylcysteine—Skin disorder—Methotrexate—muscle cancer	0.000532	0.00432	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—muscle cancer	0.000529	0.0043	CcSEcCtD
Acetylcysteine—CHUK—Adaptive Immune System—FOXO4—muscle cancer	0.000529	0.00135	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—MDM2—muscle cancer	0.000527	0.00135	CbGpPWpGaD
Acetylcysteine—Syncope—Doxorubicin—muscle cancer	0.000521	0.00423	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—muscle cancer	0.000512	0.00416	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—muscle cancer	0.000511	0.00415	CcSEcCtD
Acetylcysteine—ACY1—Metabolism—PTGS2—muscle cancer	0.000509	0.0013	CbGpPWpGaD
Acetylcysteine—Cough—Doxorubicin—muscle cancer	0.000507	0.00412	CcSEcCtD
Acetylcysteine—IKBKB—Innate Immune System—FOXO4—muscle cancer	0.0005	0.00128	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—FH—muscle cancer	0.000496	0.00127	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KIT—muscle cancer	0.000493	0.00126	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000491	0.00399	CcSEcCtD
Acetylcysteine—Dyspnoea—Methotrexate—muscle cancer	0.000488	0.00397	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—muscle cancer	0.000487	0.00396	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—muscle cancer	0.000482	0.00392	CcSEcCtD
Acetylcysteine—IKBKB—Adaptive Immune System—FOXO4—muscle cancer	0.00048	0.00122	CbGpPWpGaD
Acetylcysteine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000474	0.00385	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—muscle cancer	0.000474	0.00385	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000473	0.00384	CcSEcCtD
Acetylcysteine—CHUK—Immune System—CD34—muscle cancer	0.000472	0.00121	CbGpPWpGaD
Acetylcysteine—Shock—Doxorubicin—muscle cancer	0.000466	0.00379	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—muscle cancer	0.000463	0.00376	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—muscle cancer	0.00046	0.00374	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000458	0.00372	CcSEcCtD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000449	0.00115	CbGpPWpGaD
Acetylcysteine—Hypotension—Doxorubicin—muscle cancer	0.000443	0.0036	CcSEcCtD
Acetylcysteine—SLC7A11—Hemostasis—VEGFA—muscle cancer	0.000442	0.00113	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—VEGFA—muscle cancer	0.000435	0.00111	CbGpPWpGaD
Acetylcysteine—Urticaria—Methotrexate—muscle cancer	0.000435	0.00353	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—muscle cancer	0.000433	0.00352	CcSEcCtD
Acetylcysteine—CHUK—Signaling by NGF—MDM2—muscle cancer	0.000428	0.00109	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD34—muscle cancer	0.000428	0.00109	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—VEGFA—muscle cancer	0.000424	0.00108	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Doxorubicin—muscle cancer	0.000423	0.00343	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—muscle cancer	0.000421	0.00342	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—muscle cancer	0.000417	0.00339	CcSEcCtD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—TP53—muscle cancer	0.000409	0.00105	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000409	0.00333	CcSEcCtD
Acetylcysteine—CHUK—Innate Immune System—FOXO1—muscle cancer	0.000407	0.00104	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Methotrexate—muscle cancer	0.000403	0.00328	CcSEcCtD
Acetylcysteine—CHUK—Adaptive Immune System—FOXO1—muscle cancer	0.000391	0.000998	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—MDM2—muscle cancer	0.000388	0.000991	CbGpPWpGaD
Acetylcysteine—Pruritus—Methotrexate—muscle cancer	0.000387	0.00315	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—muscle cancer	0.000377	0.00306	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—muscle cancer	0.000375	0.00305	CcSEcCtD
Acetylcysteine—IKBKB—Innate Immune System—FOXO1—muscle cancer	0.000369	0.000942	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ENO2—muscle cancer	0.000363	0.000928	CbGpPWpGaD
Acetylcysteine—Dizziness—Methotrexate—muscle cancer	0.000362	0.00294	CcSEcCtD
Acetylcysteine—IKBKB—Adaptive Immune System—FOXO1—muscle cancer	0.000354	0.000905	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Doxorubicin—muscle cancer	0.000349	0.00284	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—muscle cancer	0.000348	0.00283	CcSEcCtD
Acetylcysteine—Rash—Methotrexate—muscle cancer	0.000345	0.00281	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—muscle cancer	0.000345	0.0028	CcSEcCtD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—muscle cancer	0.000341	0.00087	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000339	0.000866	CbGpPWpGaD
Acetylcysteine—Pruritus—Doxorubicin—muscle cancer	0.000335	0.00273	CcSEcCtD
Acetylcysteine—SLC7A11—Hemostasis—TP53—muscle cancer	0.000334	0.000852	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HMGA1—muscle cancer	0.00033	0.000843	CbGpPWpGaD
Acetylcysteine—Nausea—Methotrexate—muscle cancer	0.000325	0.00264	CcSEcCtD
Acetylcysteine—CHUK—Immune System—FOXO4—muscle cancer	0.000321	0.000819	CbGpPWpGaD
Acetylcysteine—Dizziness—Doxorubicin—muscle cancer	0.000313	0.00255	CcSEcCtD
Acetylcysteine—GRIN1—Developmental Biology—VEGFA—muscle cancer	0.00031	0.000793	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KIT—muscle cancer	0.00031	0.000792	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—VEGFA—muscle cancer	0.000303	0.000773	CbGpPWpGaD
Acetylcysteine—Vomiting—Doxorubicin—muscle cancer	0.000301	0.00245	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—muscle cancer	0.000299	0.00243	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—muscle cancer	0.000299	0.00243	CcSEcCtD
Acetylcysteine—CHUK—Adaptive Immune System—KIT—muscle cancer	0.000298	0.00076	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FOXO4—muscle cancer	0.000296	0.000756	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTGS2—muscle cancer	0.000292	0.000746	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FOXO4—muscle cancer	0.000291	0.000743	CbGpPWpGaD
Acetylcysteine—Nausea—Doxorubicin—muscle cancer	0.000282	0.00229	CcSEcCtD
Acetylcysteine—IKBKB—Innate Immune System—KIT—muscle cancer	0.000281	0.000718	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MED12—muscle cancer	0.00028	0.000715	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KIT—muscle cancer	0.00027	0.000689	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ENO2—muscle cancer	0.000255	0.000652	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MDM2—muscle cancer	0.000244	0.000623	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTCH1—muscle cancer	0.000241	0.000616	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FOXO1—muscle cancer	0.000237	0.000605	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—MDM2—muscle cancer	0.000234	0.000599	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MDM2—muscle cancer	0.000221	0.000565	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FOXO1—muscle cancer	0.000219	0.000559	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTCH1—muscle cancer	0.000219	0.000559	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FOXO1—muscle cancer	0.000215	0.000549	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—MDM2—muscle cancer	0.000213	0.000543	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FOXO4—muscle cancer	0.000207	0.00053	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CNR1—muscle cancer	0.000204	0.00052	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.0002	0.00051	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FOXO4—muscle cancer	0.000188	0.00048	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CNR1—muscle cancer	0.000185	0.000471	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KIT—muscle cancer	0.000181	0.000461	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KIT—muscle cancer	0.000167	0.000426	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF2—muscle cancer	0.000166	0.000425	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KIT—muscle cancer	0.000164	0.000418	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FOXO1—muscle cancer	0.000153	0.000391	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF2—muscle cancer	0.000151	0.000385	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MDM2—muscle cancer	0.000142	0.000363	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FOXO1—muscle cancer	0.000139	0.000355	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MDM2—muscle cancer	0.000131	0.000335	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MDM2—muscle cancer	0.000129	0.000329	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—muscle cancer	0.000127	0.000323	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KIT—muscle cancer	0.000117	0.000298	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KIT—muscle cancer	0.000106	0.00027	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MDM2—muscle cancer	9.2e-05	0.000235	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—muscle cancer	8.89e-05	0.000227	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MDM2—muscle cancer	8.34e-05	0.000213	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—muscle cancer	6.98e-05	0.000178	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—muscle cancer	6.33e-05	0.000162	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—muscle cancer	5.28e-05	0.000135	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—muscle cancer	4.78e-05	0.000122	CbGpPWpGaD
